StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Stock analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEXGet Rating) in a note issued to investors on Tuesday. The brokerage set a “buy” rating on the stock.

Separately, TheStreet raised shares of Mannatech from a “c+” rating to a “b-” rating in a report on Thursday, October 13th.

Mannatech Price Performance

MTEX opened at $16.24 on Tuesday. The company has a fifty day moving average price of $19.79 and a two-hundred day moving average price of $20.56. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.74 and a current ratio of 1.27. Mannatech has a 52 week low of $15.49 and a 52 week high of $38.30. The firm has a market capitalization of $30.19 million, a PE ratio of 7.19 and a beta of 1.17.

Mannatech (NASDAQ:MTEXGet Rating) last released its earnings results on Tuesday, November 8th. The company reported $0.61 EPS for the quarter. Mannatech had a net margin of 3.24% and a return on equity of 20.94%. The firm had revenue of $35.51 million during the quarter.

Insider Activity

In other news, Director Kevin Andrew Robbins sold 1,500 shares of the business’s stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $22.00, for a total value of $33,000.00. Following the completion of the transaction, the director now owns 11,531 shares of the company’s stock, valued at approximately $253,682. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CEO Alfredo Bala sold 3,500 shares of the business’s stock in a transaction on Wednesday, December 21st. The shares were sold at an average price of $19.69, for a total value of $68,915.00. Following the completion of the transaction, the chief executive officer now owns 4,406 shares of the company’s stock, valued at approximately $86,754.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Kevin Andrew Robbins sold 1,500 shares of the business’s stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $22.00, for a total transaction of $33,000.00. Following the completion of the transaction, the director now directly owns 11,531 shares of the company’s stock, valued at approximately $253,682. The disclosure for this sale can be found here. 50.00% of the stock is owned by company insiders.

Hedge Funds Weigh In On Mannatech

A hedge fund recently raised its stake in Mannatech stock. LSV Asset Management boosted its stake in Mannatech, Incorporated (NASDAQ:MTEXGet Rating) by 1,090.3% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,142 shares of the company’s stock after acquiring an additional 6,542 shares during the quarter. LSV Asset Management owned 0.37% of Mannatech worth $261,000 as of its most recent SEC filing. Institutional investors and hedge funds own 24.90% of the company’s stock.

About Mannatech

(Get Rating)

Mannatech, Inc engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L.

See Also

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.